Form D · Biotechnology
Periphagen Holdings, Inc.
Pittsburgh, PA · CIK 0001601176
Offering snapshot reported Mar 31, 2014 · SEC filing
- Reported sold
- $6.5M Offering amount: $16M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $6.5M Reported outside-investor minimum
- First sale
- Mar 17, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 31, 2014 | Initial | $6,500,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-214599
Remaining offered shares purchasable upon achievement of milestones.
Source: Form D, filed Mar 31, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Krisky | Director |
| James Wechuck | Director, Executive |
| Darren Wolfe | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2100 Wharton St., Suite 701
Pittsburgh, PA, 15203
Pittsburgh, PA, 15203